Skip to main content
. 2013 Dec 18;5(3):634–648. doi: 10.18632/oncotarget.1596

Fig 7. TQ enhances the effect of bortezomib against MM tumor cell proliferation.

Fig 7

A, immunohistochemical analysis of the pro-angiogenic growth factor VEGF expression in mice treated with TQ either alone or in combination with bortezomib. Right, quantification of VEGF positive cells as described in Materials and Methods. Columns, mean; bars, SD; *, p < 0.05. B, immunohistochemical analysis of the survival protein Bcl-2 expression in mice treated with TQ either alone or in combination with bortezomib. Right, quantification of Bcl-2 positive cells as described in Materials and Methods. Columns, mean; bars, SD; *, p < 0.05. C, immunohistochemical analysis of caspase-3 expression in mice treated with TQ either alone or in combination with bortezomib. Right, quantification of caspase-3 positive cells as described in Materials and Methods. Columns, mean; bars, SD; *, p < 0.05